Definium Therapeutics' LSD-Based Psych Drug Scores Again
· investors.com
Definium Therapeutics unveiled the second of two positive Phase 3 studies for its LSD-based drug. The biotech stock surged on the results.
Definium Therapeutics (DFTX) unveiled the second of two positive Phase 3 studies for its LSD-based drug. The biotech stock surged on the results. Patients with ...